Hexarelin 5 mg
Peptide Hubs

Hexarelin 5 mg

EXAMORELIN 5 MG INJECTION
Drug Class: Growth Hormone-Releasing Peptide (GHRP-6 Analog)
Composition:
- Active Substance: Examorelin (Hexarelin)
- Concentration: 5 mg per vial
Presentation: 2 mL Vial
Form: Lyophilized Powder for Reconstitution
Manufacturer: Peptide Hubs

$41.40 $69.00
Shipping From:
International
You will save $27.60

Peptide Hubs Hexarelin 5 mg: Potent Growth Hormone Secretagogue for Research

Peptide Hubs introduces Hexarelin 5 mg, a powerful synthetic hexapeptide and growth hormone-releasing peptide (GHRP) analog designed for advanced endocrine research. Known chemically as Examorelin, this compound is recognized for its potent and reliable stimulation of growth hormone (GH) secretion from the pituitary gland. Provided as a 5 mg lyophilized powder in a sterile 2 mL vial, Hexarelin offers researchers a highly effective tool for investigating the systemic effects of elevated GH and IGF-1 levels. Its mechanism involves binding to the ghrelin receptor (GHS-R1a), triggering a robust pulse of GH release. As noted in scientific literature on GHRPs, Hexarelin is among the most potent secretagogues in its class. Peptide Hubs ensures pharmaceutical-grade purity, providing the consistency required for controlled studies on anabolism, recovery, and body composition.

Effects of Hexarelin 5 mg

The primary research effect of Hexarelin is a significant, dose-dependent increase in pulsatile growth hormone secretion. This elevated GH, in turn, stimulates the production of Insulin-like Growth Factor-1 (IGF-1) in the liver and locally in tissues, leading to a cascade of anabolic and metabolic outcomes in study models:

  • Enhanced Muscle Growth & Protein Synthesis: The GH/IGF-1 axis is a primary driver of anabolism. Research investigates Hexarelin's potential to increase lean body mass, promote nitrogen retention, and stimulate the hypertrophy of both muscle and connective tissue.
  • Significant Fat Loss & Lipolysis: Growth hormone has potent lipolytic effects. Studies examine Hexarelin's role in promoting the breakdown of stored triglycerides in adipose tissue, particularly stubborn visceral fat, leading to improvements in body composition.
  • Improved Recovery & Sleep Quality: GH is crucial for tissue repair and is secreted naturally during deep sleep. Research models explore Hexarelin's potential to accelerate recovery from exercise-induced microtrauma and, through its influence, potentially deepen sleep architecture.
  • Strengthened Connective Tissues & Bone Density: The GH/IGF-1 pathway stimulates collagen synthesis. Research focuses on its effects on tendon, ligament, and bone strength, which is vital for injury prevention and structural integrity.
  • Enhanced Cellular Hydration & Nutrient Uptake: GH promotes fluid and electrolyte retention within cells (including muscle cells), creating a fuller, more anabolic intracellular environment and improving nutrient partitioning.

Recommended Dosage & Administration for Research

Hexarelin is a potent research peptide, and all dosing is for controlled laboratory studies. The 5 mg vial is typically reconstituted with 2 mL of bacteriostatic water, yielding a concentration of 2.5 mg/mL. In experimental models, dosing is often in the range of 1-2 micrograms per kilogram of body weight (µg/kg). Due to its mechanism of mimicking natural pulsatile GH release, research protocols commonly administer it 2-3 times per day, typically in a fasted state (before meals and before bedtime). Administration is via subcutaneous injection. Cycles in research are usually limited to 4-8 weeks to prevent desensitization of the pituitary response. Meticulous timing, dosing accuracy, and sterile technique are critical for valid data.

Potential Research Cycles & Experimental Stacking

Hexarelin is studied in relatively short, pulsed cycles to maximize GH response and minimize receptor downregulation. For comprehensive investigations into maximal anabolism and physique enhancement, researchers design protocols combining Hexarelin with complementary compounds. These are concepts for scientific study design.

  • For Maximal GH/IGF-1 Elevation: Research often stacks Hexarelin with a Growth Hormone-Releasing Hormone (GHRH) analog like CJC-1295 No DAC 5 mg or Tesamorelin. This combination synergistically increases GH pulse amplitude and duration.
  • For Muscle Growth & Recovery: Studies on hypertrophy may combine it with localized repair factors like PEG MGF 5 mg and systemic anabolic support like IGF-1 LR3.
  • For Fat Loss & Metabolic Enhancement: To study extreme body recomposition, researchers might pair it with potent lipolytic agents like AOD 9604 5 mg or metabolic stimulants such as T3.
  • For Anti-Aging & Cellular Repair: Research into longevity might stack it with foundational cofactors like NAD+ 500 mg and mitochondrial protectants like SS-31 50 mg.
  • For Post-Cycle Therapy (PCT) & Recovery: In models of hormonal recovery, Hexarelin may be studied alongside SERMs like Clomid or peptides like Kisspeptin 10 mg to support the natural HPT axis while maintaining an anabolic environment.

Possible Side Effects & Research Considerations

In research models, Hexarelin's potent GH-releasing action is associated with a predictable set of transient side effects. The most common is a significant increase in hunger due to its action on the ghrelin receptor. Others include transient flushing, tingling sensations, headaches, and lethargy following injection—symptoms often associated with a strong GH pulse. A notable research consideration is its potential to elevate cortisol and prolactin levels in some studies. Prolonged use can lead to desensitization (tachyphylaxis), where the pituitary's response diminishes. There is also a theoretical risk of acromegalic-like tissue growth with chronic, excessive dosing. The standard risks of infection, improper dosing, and lack of ethical oversight apply.

Mechanism of Action & Research Significance

Hexarelin's research value lies in its specificity and potency. It acts as a potent agonist at the Growth Hormone Secretagogue Receptor (GHS-R1a), the same receptor activated by the natural hunger hormone ghrelin. This binding triggers a intracellular cascade involving phospholipase C and protein kinase C, leading to a strong, synchronous release of stored growth hormone from the somatotroph cells of the anterior pituitary. Unlike GHRH analogs which modulate the frequency of GH pulses, Hexarelin primarily increases the amplitude (size) of each pulse. This makes it an excellent tool for studying the acute effects of large GH spikes on metabolism, protein synthesis, and lipolysis, and for investigating the interplay between hunger signaling and the somatotropic axis.

Frequently Asked Questions (FAQ)

How does Hexarelin differ from GHRP-6 or Ipamorelin?

All three are GHRPs, but with key differences. Hexarelin is the most potent in stimulating GH release. GHRP-6 is slightly less potent but has a stronger effect on hunger stimulation. Ipamorelin is the least potent but is considered more selective, with minimal effects on cortisol, prolactin, and appetite. For research, Hexarelin is chosen for studying maximal GH pulse amplitude, while Ipamorelin is used for studies requiring a cleaner side-effect profile.

Why is multiple daily dosing used in Hexarelin research?

This protocol mimics the body's natural pulsatile GH secretion pattern (several large pulses per day). Administering Hexarelin 2-3 times daily—typically upon waking, pre-workout, and before bed—allows researchers to study the effects of amplifying these natural pulses. This approach is also used to potentially avoid sustained elevation that could lead to faster feedback inhibition and receptor desensitization.

What is the standard reconstitution protocol for the 5 mg vial?

Reconstitute with 2 mL of bacteriostatic water for a final concentration of 2.5 mg/mL (2500 mcg/mL). This means each 0.1 mL (10 units on an insulin syringe) contains 250 mcg of Hexarelin, allowing for precise dosing in the common research range of 100-300 mcg per administration. Gently swirl to dissolve; avoid shaking.

Can Hexarelin cause cortisol or prolactin increases in research models?

Yes, this is a documented research observation. Unlike the more selective Ipamorelin, Hexarelin can stimulate a mild increase in adrenocorticotropic hormone (ACTH) and prolactin release in some models. This is an important consideration for study design, especially in long-term protocols or when stacking with other compounds that affect these hormones. Monitoring these parameters is part of responsible experimental design.

No reviews found

Please log in to write Hexarelin 5 mg review.

Related Offers
Lab Tested
Domestic & International
NEW
Only 1 month left with this price
-40% OFF
Hexarelin 5 mg
Dragon Pharma, Europe

EXAMORELIN 5 MG INJECTION
Drug Class: Growth Hormone Secretagogue
Composition:
- Active Substance: Examorelin
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report

$45.00 $75.00
You will save $30.00
Lab Tested
Domestic & International
Only 1 week left with this price
-50% OFF
Trenbolone 200 mg
Dragon Pharma, Europe

TRENBOLONE ENANTHATE 200 MG INJECTION
Drug Class: Androgen; Anabolic Steroid; Androgen Ester; Progestogen
Composition:
- Active Substance: Trenbolone Enanthate
- Concentration: 200 mg/mL
Presentation: 10 mL Vial
Manufacturer: Dragon Pharma
Common Name(s): Trenabol, Trenbolone Heptanoate
Tested in Laboratory: View Lab Report

$67.00 $134.00
You will save $67.00
Domestic & International
Only 1 month left with this price
-40% OFF
Sermorelin 5 mg
Dragon Pharma, Europe

SERMORELIN 5 MG INJECTION
Drug Class: Growth Hormone-Releasing Hormone (GHRH)
Composition:
- Active Substance: Sermorelin
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma

$27.00 $45.00
You will save $18.00
Domestic & International
Only 1 month left with this price
-40% OFF
PT-141 10 mg
Dragon Pharma, Europe

BREMELANOTIDE 10 MG INJECTION
Drug Class: Selective Melanocortin Receptor Agonist
Composition:
- Active Substance: Bremelanotide
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma

$27.00 $45.00
You will save $18.00
Lab Tested
Domestic & International
Only 1 month left with this price
-40% OFF
BPC 157 5 mg
Dragon Pharma, Europe

PENTADECAPEPTIDE 2 MG INJECTION
Drug Class: Healing/Repair Peptide
Composition:
- Active Substance: Pentadecapeptide
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report

$24.00 $40.00
You will save $16.00

Add to Cart - Product(s)

Close Button
Empty

Total Cost: